INTRODUCTION
During mammalian embryonic development, the fetoplacental structure transfers nutrients from the maternal to the fetal circulation. Although some of the nutrients are translocated passively (e.g. gases) or diffuse in a facilitated manner (e.g. sugars) by virtue of concentration gradients, most of the nutrients are probably transported actively, i.e. in an energy-dependent fashion, across the placental barrier (Miller et al., 1976; Hill & Longo, 1980; Truman & Ford, 1984) .
For calcium, it has been shown that its concentration is higher in the fetal blood than in the maternal blood, and the experimental evidence available in the literature (Delivoria-Papadopoulos et al., 1967; Twardock & Austin, 1970; Tan & Raman, 1972; McIntosh & Lutwak-Mann, 1974; van Kreel & van Dijk, 1983; Sweiry & Yudilevich, 1984) are all strongly suggestive of an active up-gradient calcium-transport mechanism in the mammalian placenta. However, the inherent tissue complexity of the placenta, a result of intimate interactions between maternal and fetal cell types, has greatly limited the understanding of the basic mechanism of active calcium transport in the placenta.
We have been investigating transplacental calcium transport by identifying specific macromolecules associated with the transport function. The systems we have studied include the chick embryonic chorioallantoic membrane (CAM) (Tuan & Scott, 1977) and the human placenta (Tuan, 1982) . The avian CAM, derived from the fusion of the chorionic and allantoic membranes during early development, lines the internal surface of the eggshell and is responsible for the mobilization and translocation of shell calcium into the embryonic circulation throughout embryonic development (Terepka et al., 1976) . The relative simplicity of the CAM, owing to the absence of maternal tissues, makes it an attractive experimental model for the study of placental calcium transport. Our previous studies have clearly demonstrated the involvement of a specific calcium-binding protein (CaBP) which is expressed in the chick CAM concomitantly with the onset of calcium-transport activity (Tuan & Scott, 1977; Tuan & Zrike, 1978) . The chick CAM CaBP has been purified and characterized (Tuan et al., 1978a) , and localized to specific calcium-transporting cells of the CAM (Tuan et al., 1978b ). Subsequently we have identified a specific Ca2+-activated ATPase, which also appears to be associated with CAM calcium transport (Tuan & Knowles, 1984) . In the human placenta, our study has also indicated the presence of a specific, high-Mr, calcium-binding protein (HCaBP) (Tuan, 1982) , and our most recent findings strongly suggest its functional involvement in placental calcium uptake (Tuan, 1985) . Thus the identification of these specific marker molecules, such as CaBPs, has provided valuable experimental means for the biochemical analysis of transplacental calcium transport.
In the present study, prompted by our previous findings, we present data showing the presence of a specific, high-Mr, calcium-binding protein (MCaBP) in the mouse chorioallantoic placenta. The MCaBP has been purified to homogeneity and is different from a low-Mr calcium-binding protein previously discovered in rodent placentae (Marche et al., 1978; Bruns et al., 1978) . The MCaBP has been characterized with respect to its physicochemical and immunochemical properties and its cellular location.
MATERIALS AND METHODS Animals
Mice (females, C57BL; males, SJL) were obtained from the Jackson Laboratory (Bar Harbor, ME, U.S.A.). Mating was carried out randomly, and the first presence of a vaginal plug in the female was counted as day zero of gestation. New Zealand White rabbits were used for raising antibodies.
Extraction of placenta
At specific gestational time intervals, pregnant females were killed by cervical dislocation. The uterus was cut open and the chorioallantoic placental plugs were dissected clear from the amniotic sac and uterine wall, rinsed thoroughly in cold 0.9% NaCl, and were either used immediately or frozen at -70°C until use. The placental Abbreviations used: CAM, chorioallantoic membrane; CaBP, calcium-binding protein; SDS, sodium dodecyl sulphate.
tissues were minced and homogenized in a buffer containing 13.7 mM-Tris/HCI, pH 7.4, 0.12 M-NaCl, 4.74 mM-KCl and 0.02% NaN3 (Tuan, 1982) . The soluble placental extract was defined as the supernatant obtained after centrifugation at 31 000 g for 30 min. All operations were carried out at 4 'C.
Assay for calcium-binding activity (A) Chelex assay. Calcium-binding activity was measured as previously described (Tuan & Scott, 1977) by the Chelex 100 (Bio-Rad) ion-exchange method, with 45Ca (Amersham) as a tracer. Units of calcium-binding activity were calculated as (radioactivity in supernatant)/(radioactivity retained by resin) and expressed as a percentage value. All samples were extensively dialysed against the above Tris buffer before assay for calcium-binding activity in duplicates.
(B) Analysis of electrophoretogram. Proteins separated electrophoretically on a native polyacrylamide-gel system (see below) were assayed for calcium-binding activity by the counter-ion electrophoresis method of Ueng & Bronner (1979) and the post-electrophoresis method of Schibeci & Martonosi (1980) (details described in the legend to Fig. 7 ).
Protein determination
Protein concentration was determined by the method of Lowry et al. (1951) , with bovine serum albumin (Sigma) as a standard.
Purification of MCaBP
The final procedure adopted for purifying MCaBP from extracts of mouse placentae included two steps of chromatography: gel filtration on a column of Bio-Gel A-1.5 m (Bio-Rad) and ion-exchange chromatography on a Mono Q anion-exchange column (FPLC System; Pharmacia). The experimental details of these steps are described in the legends to Table 1 Laemmli & Favre (1973) , with 4% and 10% acrylamide for the stacking and separating gels respectively. Gels were routinely stained with Coomassie Blue R-250.
(B) Native gel. The conditions were those of Davis (1964) , with a tank buffer of Tris/glycine, pH 8.6. Separating gels ranged from 4 to 10% acrylamide concentration, and electrophoresis was carried out at 8°C.
Isoelectric focusing
Flat-bed isoelectric focusing was carried out on the LKB Multiphor unit by using both polyacrylamide gel and granulated gel superfine; Pharmacia) according to the manufacturer's instructions: 25 W, 2 h for polyacrylamide gel and 8 W, 18 h for granulated gel. The pH gradient across the focused gel was determined by using a flat-surface combination pH-electrode (Phoenix Electrodes). The polyacrylamide gel was fixed in trichloroacetic acid and stained with Coomassie Blue; the granulated gel was fractionated with a steel grid (LKB) and eluted with Tris buffer.
Preparation of anti-MCaBP antibodies Purified MCaBP (approx. 100 ,ug), cut out as a Coomassie-Blue-stained band from an SDS/polyacrylamide gel, was homogenized with 2 ml of a 1: 1 (v/v) mixture of the Tris buffer and Freund's Complete Adjuvant (Cappel Laboratories) and injected subcutaneously into each of two rabbits. Sera were collected from the immunized rabbits 5 weeks after the injection. A second injection with approx. 20 ,g of MCaBP in Freund's Incomplete Adjuvant was performed 8 weeks later, and sera were collected every 2 weeks afterwards.
Immunochemical procedures (A) Immunodiffusion. Ouchterlony double immunodiffusion was performed as described previously (Tuan et al., 1978b) in 1 % agarose containing barbital buffer, pH 8.6.
(B) Immunoblotting. Electrophoretically separated proteins were electrotransferred on to nitrocellulose in an ElectroBlot Apparatus (E-C Apparatus) by using the manufacturer's protocol. For immunodetection, the protein blot was then sequentially reacted with antiMCaBP antiserum and peroxidase-labelled goat anti-(rabbit IgG) (Sigma) by the procedure of Towbin et al. (1979) , and developed histochemically with 4-chloro-1-naphthol as the peroxidase substrate (Hawkes et al., 1982) .
Fluorescence immunohistochemistry
The MCaBP was localized by indirect immunofluorescence histochemistry by a procedure similar to that used previously for the chick CAM (CaBP, Tuan et al., 1978b; carbonic anhydrase, Tuan, 1984) and the human placenta (HCaBP; Tuan, 1985) . Immunostaining was carried out on cryosections (6-8 ,um) of mouse placenta by using rabbit-derived anti-MCaBP antiserum (1: 25 dilution) as the primary antibody and fluorescein isothiocyanatelabelled sheep anti-(rabbit IgG) (1:25 dilution, Behring Diagnostics) as the secondary antibodies. Controls included exclusion of the anti-MCaBP antiserum or its replacement with pre-immune serum. The sections were observed under phase and fluorescence optics with an Olympus BH2 photomicroscope equipped with a 100 W mercury lamp. All photography was done on Kodak Tri-X film.
RESULTS

Identification of calcium-binding activity
In initial experiments, an extract of mouse placenta obtained on day 19-20 of gestation was tested for calcium-binding activity by the Chelex assay. The results in Fig. 1 clearly demonstrated that the extract contained a heat-labile and proteinase-sensitive ( Fig. 1, inset) calcium-binding activity. The validity of the assay was indicated by the linearity of the activity (up to 15 units) with respect to sample size. Activity during gestation
We next determined whether placental calcium-binding activity showed any temporal correlation with the increasing calcium need of the developing embryo (Bruns et al., 1978; Greizerstein & Abel, 1979) . It was assumed that, if the calcium-binding activity were involved in The soluble extract (9.4 mg of protein/ml) was prepared from gestation-day 19-20 chorioallantoic placentae, and calcium binding was assayed by the Chelex method, where 1 activity unit = (supernatant radioactivity)/(resin radioactivity) expressed as a percentage (see the Materials and methods section). The inset shows sensitivity of placental calcium-bindingactivity to proteinases andheat. Incubation of the extract with proteinases (trypsin and Pronase) was carried out at enzyme concentrations of 1 mg/ml for 15 min at 37 'C. Thermal treatment was at 100 'C for 5 min. All activities were expressed as percentages of control. (Note: incubation of the extract at 37 'C for 15 min in the absence of added proteinases resulted in no change of activity.) transplacental calcium transport, it ought to increase as a function of gestation. As shown in Fig. 2 , the specific activity of calcium binding in placental extracts indeed exhibited an age-specific increase. Characterization of calcium-binding activity
The proteinaceous nature of the calcium-binding activity was indicated above (Fig. 1) by its sensitivity to specific (trypsin) and non-specific (Pronase) proteinases and was also consistent with its thermal lability. It was observed that a minor residual calcium-binding activity, representing approx. 20% of the total, remained after heating (100°C) and was probably due to nonproteinaceous component(s). As demonstrated below, the calcium-binding activity in the placental extract is primarily due to a high-Mr calcium-binding protein (MCaBP) .
The specificity of the calcium-binding activity in mouse placental extract was estimated by determining the relative ability of various metal cations to compete with 45Ca in the Chelex-binding assay (Fig. 3) . It was observed that non-radioactive 40Ca was capable of effectively displacing 45Ca, whereas other bivalent (or tervalent) cations were either totally ineffective or only partially effective as competitive ligands. The following ion affinity series was apparent: Ca > Sr > Cd, Co, Fe(III) > Sn > Ni, Mg, Mn > Zn. These results strongly suggest that a specific ionic structure, that of calcium, is probably required for binding to the MCaBP of the mouse placenta.
Further characterization of the placental calciumbinding activity with respect to pH and ionic-strength dependence showed that optimal activity occurred at (Weast, 1975 ).
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Purification of the MCaBP
In initial experiments, we used a purification scheme involving sequential (NH4)2S04 precipitation, gel filtration and preparative isoelectric focusing, which was similar to that previously used for the CaBP of human placenta (Tuan, 1982) and of chick CAM (Tuan et al., 1978a) . Although satisfactory purification was occasionally obtained, the length of time required for the procedure caused significant aggregation and degradation of the preparation, as revealed by chromatography and electrophoresis. Consequently, a shorter and more efficient procedure was devised and adopted as described below and in the legends to Figs 4 and 5. All steps were carried out at 4 'C.
Step 1: gel filtration. Freshly prepared mouse placental extract was concentrated in a dialysis sac by immersion in Aquacide III (Calbiochem) for 3-5 h (10-15 g of tissue routinely yielded approx. 10 ml of concentrated extract, with 10-20 mg of protein/ml). The extract was then fractionated by gel filtration in a Bio-Gel A-1.5 m column (2.5 cm x 95 cm). The chromatogram in Fig. 4 showed that two distinct calcium-binding activity peaks (I and II) were resolved. Since the smaller peak II most probably consisted of the low-Mr CaBP previously identified Concentrated day-18-19 placental extract (10 ml, containing approx. 25 mg of protein/ml) was loaded on a Bio-Gel A-1.5 m (Bio-Rad) column (2.5 cm x 90 cm), which was eluted with the Tris buffer at a flow rate of 20 ml/h; 4.4 ml fractions were collected and protein contents were monitored as A280. Calcium-binding activities were assayed by the Chelex 100 method (see the Materials and methods section). Peaks I and II were consistently observed to be the major calcium-binding components in the chromatogram, whereas the middle minor peak was only occasionally observed. Protein was determined by the method of Lowry et al. (1951) . Calcium-binding activity was determined by the Chelex 100 assay (see the Materials and methods section). The placental extract was prepared from the chorioallantoic placentae obtained at day 17-18 of gestation. The gel-filtration step fractionated the high-M, MCaBP from the low-Mr vitamin D-dependent CaBP, and their activities were approx. 55% and 45%, respectively, of the total activity in the original extract (Fig. 4) . The values for % yield in parentheses represented an estimation of the actual recovery of the MCaBP by taking the above into consideration. (Bruns et al., 1978 (Bruns et al., , 1981 Delorme et al., 1982 ; also see the Discussion section), only the fractions constituting the major, higher-Mr, activity peak were pooled for further fractionation.
Step 2: ion-exchange chromatography. This was carried out on a Mono Q anion-exchange column of the Pharmacia FPLC system (Fig. 5a) . A single peak of calcium-binding activity was eluted coincidently with an A280 peak at approx. 75% buffer B (0.35 M-NaCl) and represented the purified MCaBP. The efficacy of the purification procedure and homogeneity of the MCaBP preparation was routinely monitored by SDS/polyacrylamide-gel electrophoresis (Fig. 5b) . Representative yield and recovery of the MCaBP purification scheme are shown in Table 1 .
The purified MCaBP in Tris buffer rapidly lost its activity with storage at either 4°or -70 'C. The cause of this instability was not known; various manipulations, such as addition of reducing agents (e.g. dithiothreitol), glycerol and/or proteinase inhibitors, or varying the buffer ionic strength, failed to stabilize the MCaBP. The lability of the MCaBP probably contributed to the low recovery indicated in Table 1 . For this reason, most of the experiments on characterization of the MCaBP were carried out on gel-filtration-enriched preparations.
M, of MCaBP
The Mr ofnative MCaBP was determined by (1) h.p.l.c. gel-permeation chromatography and (2) native gel electrophoresis.
Gel-permeation chromatography of the purified MCaBP preparation was carried out on a TSK G3000SW column (Alltech Associates, Deerfield, IL, U.S.A.) with the Pharmacia FPLC system. The chromatogram (Fig. 6 ) revealed a single protein peak corresponding to a Mr of 56000-58000.
The Mr ofthe native MCaBP was also determined from its electrophoretic mobility in polyacrylamide gels of different percentages of cross-linking. The MCaBP was localized in the gel by means of: (1) counter-ion electrophoresis (Ueng & Bronner, 1979) in which 45Ca placed in the anode-buffer tank migrated upward towards the cathode during electrophoresis and was chelated to the downward-moving MCaBP; or (2) binding of 45Ca by the MCaBP. Subsequent autoradiography of the dried gels permitted observation of the MCaBP (Fig. 7) . These data were analysed by Ferguson plots (Chrambach, 1980) , on the basis of which the retardation coefficient (Kr) of the MCaBP was compared with those of other globular proteins of known Mr (Fig. 8) Ueng & Bronner (1979) . A tracer amount of 45Ca (0.5 x 106 c.p.m./ml) was included in the bottom buffer tank, and electrophoresis was then carried out in a discontinuous buffer system (Davis, 1964 (Davis, 1964) containing 45Ca (2.5 x 106 c.p.m./ml). The gel was then washed in buffer and water to remove excess unbound 45Ca. In both procedures, the 45Ca-labelled gel was dried under vacuum at room temperature and autoradiography was done with Kodak XAR-Omat film at -70 'C. [Note: In counter-ion electrophoresis (a), 1 mM-EDTA was included in the sample buffer to decrease the background of 45Ca in the gel, which was vacuum-dried without washing. This accounted for the high radioactive exposure in non-sample-lane areas of the gel, whereas the sample lanes were relatively clear of radiolabel in order to reveal the 45Ca-bound MCaBP.]
Isoelectric point of MCaBP
The elution of the MCaBP at 0.35 M-NaCl from the anion-exchange Mono Q column strongly suggested its highly acidic nature. Initial isoelectric-focusing experiments using wide-range (pH 3-10) ampholytes in agarose or polyacrylamide gel localized the MCaBP to a zone corresponding to a pl of 4.6-4.8 (results not shown). Further experiments using narrow-range ampholytes (pH 4-6) yielded a value of 4.70 for the pI of the MCaBP (Fig. 9) , based on the analysis of more than five different batches of MCaBP preparations. Anti-MCaBP antiserum and immunological properties The specificity of the rabbit-derived anti-MCaBP antiserum was tested by means of Ouchterlony double immunodiffusion (Fig. lOa) immuno-specificity was obtained from post-electrophoresis immunoblotting oftotal mouse placental extract (Fig. l Ob), which revealed a single band ofimmunoreactive protein with Mr 57000 (lane C). By means ofdouble immunodiffusion, the MCaBP was also examined with respect to its immunological cross-reactivity with other CaBPs previously identified in this laboratory, i.e. the HCaBP of the human placenta (Tuan, 1982) and the CaBP of the chick embryonic CAM (Tuan et al., 1978a) . Specifically, the reactivity of each of the specific antisera was tested against each tissue extract. The results (not shown) indicated that there was significant cross-reactivity between the HCaBP and MCaBP, but that neither one shared any common properties with the chick CaBP. In addition, it was found that the MCaBP was also detectable in the mouse choriovitelline placenta (yolk-sac) of day-17 mouse embryo, although the specific activity was significantly () 8-fold) lower than that in the chorioallantoic placenta. isoelectric focusing in Sephadex G-75 using pH 4-6 ampholytes (Isolab) The procedure was carried out as described in the Materials and methods section and the sample was the pooled Peak I (approx. 8 mg of protein) obtained after gel filtration (Fig. 4) . After focusing, the pH across the gel was measured with a surface pH electrode. The gel was then fractionated and assayed for calcium-binding activity as described in the Materials and methods section. The high activity in the acidic fractions was an artifact owing to the presence ofH3P04 in the anode solution (see Tuan & Scott, 1977) . labyrinth structure consisting of interwoven fetal and maternal vascular structures lined by fetal trophoblastic cells (Ramsey, 1975; see Fig. 1 la) . As shown in Figs. 11(b) and 11(c), the immunofluorescent staining ofMCaBP was primarily associated with the syncytiotrophoblast layer. Moreover, the fluorescent staining appeared to be most intense in the cortical regions of the trophoblasts, often outlining the cell borders. This distribution of the MCaBP was suggestive of a plasma-membrane association, although the limited resolution of the light-microscope did not permit a definitive localization. Finally, controls omitting anti-MCaBP serum or replacing it with pre-immune serum yielded no detectable fluorescence (Figs llc and IlId).
DISCUSSION
Our investigation has shown that the mouse chorioallantoic placenta contains a specific high-Mr calciumbinding protein (MCaBP), which is expressed as a function of gestational age. A relatively simple three-step procedure has been devised to permit the isolation of homogeneous preparations of the MCaBP. In particular, the anion-exchange-chromatography step using the FPLC Mono Q column represented an efficient and quick (< 1 h) method of fractionation. Cation-binding by the MCaBP displays a high degree of stereospecificity (Fig. 3a) and therefore does not appear to be a result of simple electrostatic or ionic interactions (Diamond & Wright, 1969 Hancock & Tsang (1983) ; lane C, immunohistochemically stained nitrocellulose blot, revealing a single band of Mr 57000, which was identical with that of purified MCaBP (Fig. 5b) . Protein Mr standards (Std.) were from Sigma.
its molecular properties, the MCaBP does not appear to resemble any of the previously known calcium-binding proteins (Kretsinger, 1976; Van Eldik et al., 1982) , although some degree of cross-immunoreactivity exists with the human placental HCaBP (Tuan, 1982) . The development-and tissue-specific onset of the appearance of the MCaBP in the mouse chorioallantoic placenta is highly suggestive of its possible functional involvement in transplacental calcium transport. In rodents, such as the mouse, two placentations are operative to bring about nutrient transfer from the mother to the fetus (Ramsey, 1975) . In the first half of gestation, before gestation day 13-14, the choriovitelline (yolk sac) placenta is principally involved, whereas during late gestation the chorioallantoic placenta is the active tissue. Since embryonic calcium demand is highest during late gestation, when rapid skeletal growth and mineralization are taking place (Garel, 1983) , it is reasonable to presume that the chorioallantoic placenta is the major calcium-transporting placenta. Our finding that the MCaBP is primarily associated with the chorioallantoic placenta is thus consistent with the MCaBP being associated with placental calcium transport. Further circumstantial support for this notion is provided by immunohistochemistry. Our observations revealed that, within the haemochorial labyrinth of the mouse placenta, the MCaBP is principally associated with the syncytiotro- phoblastic layer, which constitutes the cellular boundary between maternal and fetal circulations. We have obtained evidence, based on an assay system of membrane vesicles in vitro, that the HCaBP of the human placenta is indeed functionally involved in transmembrane calcium uptake (Tuan, 1985) . Specifically, we found that anti-HCaBP antibodies inhibited calcium uptake by human placental microsomal vesicles. A similar in vitro assay system should be applicable for investigating the functional involvement ofthe MCaBP in mouse placental calcium transport.
A low-Mr (10000) CaBP has been previously found in mouse and rat placentae (Bruns et al., 1978; Marche et al., 1978) . This CaBP is identical with the vitamin D-dependent CaBP of the rodent intestine (Bruns et al., 1977) and is present in both the yolk sac and chorioallantoic placentae during embryonic development (Delorme et al., 1982) . The vitamin D dependence of the expression of this CaBP and of placental calcium transport is still controversial (Halloran & DeLuca, 1979 Garel et al., 1981; Bruns et al., 1982; Durand et al., 1983; Miller et al., 1983; Brommage & DeLuca, 1984) , and its functional role, if any, in transplacental calcium transport remains to be established. During MCaBP isolation, as reported here, the presence of the low-Mr vitamin D-dependent CaBP is consistently observed, and it is fractionated away from the MCaBP on the basis of their different biochemical properties. Furthermore, using the anti-MCaBP antiserum, we have observed no immunoreactivity in the low-Mr fraction of the placental extract. It is therefore highly unlikely that the two CaBPs are related, although it should be of great interest to elucidate the interrelationship between their functional roles (if any) in transplacental calcium transport.
